5万亿国际巨头，加注一家白蘑菇公司

Core Viewpoint - KKR has announced a new round of investment in Sylvan, a leading global mushroom cultivation and fungal biotechnology company, through its managed dollar and RMB funds, including its first RMB fund [1] Group 1: Company Overview - Sylvan is backed by Jiangsu Yuguan Modern Agricultural Technology Co., Ltd., founded by Huang Jianguang, known as the "Mushroom King" in China [2] - Huang Jianguang started his mushroom business in the 1980s, leading to significant market share in canned mushrooms, with his company producing 68% of the canned mushrooms exported from China to the U.S. [4] - Jiangsu Yuguan was established in 2010 to cultivate high-quality fresh white mushrooms, which account for 40% of the edible mushroom market globally [4] Group 2: Investment Details - KKR's initial investment in Jiangsu Yuguan was approximately 2 billion RMB, which helped the company become the largest single production unit for white mushrooms globally [4] - KKR facilitated the full acquisition of Sylvan and its research laboratories by Jiangsu Yuguan, expanding its global operational footprint [5] - The latest investment aims to support Sylvan's expansion plans, including capacity enhancement, R&D strengthening, and product line diversification in the rapidly industrializing Asian mushroom and bioproducts market [5] Group 3: KKR's Investment Strategy - KKR's assets under management (AUM) reached $723 billion (approximately 5 trillion RMB) as of September 30, 2025, with a diverse portfolio across private equity, private credit, and real estate [7] - KKR has been actively increasing its investments in Chinese assets, including the establishment of its first onshore RMB fund in Shanghai [6][7] - The firm recently completed a $2.5 billion (approximately 17 billion RMB) fundraising for an Asian private credit fund, focusing on high-quality credit assets in the Asia-Pacific region [7][8]